cover
Article Per Year (5 Year)
All
Home Page
OAI Link
Editorial Team
Contact
Reviewer
Google Scholar
Contact Name
Unang arifin
Contact Email
bcsp@unisba.ac.id
Phone
+6289691247094
Journal Mail Official
bcsp@unisba.ac.id
Editorial Address
UPT Publikasi Ilmiah, Universitas Islam Bandung. Jl. Tamansari No. 20, Bandung 40116, Indonesia, Tlp +62 22 420 3368, +62 22 426 3895 ext. 6891
Location
Kota bandung,
Jawa barat
INDONESIA
Bandung Conference Series: Pharmacy
Published by Universitas Islam Bandung
ISSN : -     EISSN : 28282116     DOI : https://doi.org/10.29313/bcsp.v2i2
Core Subject : Health, Science,
Chemistry Medicine & Pharmacology Public Health
Bandung Conference Series: Pharmacy (BCSP) menerbitkan artikel penelitian akademik tentang kajian teoritis dan terapan serta berfokus pada Farmasi dengan ruang lingkup Airlock system Kanker, Alcohol, Antelmintik, Antigastritis drugs, Antioksidan, Artemia franciscana, Ascaris suum, Cacing babi (Ascaris suum Goeze), Contact Bioautography TLC, Daun cincau hijau (Cyclea barbata Miers), Daun kelor (Moringa oleifera Lam), Diabetes mellitus, DPPH Flavonoid, Fenilpropanolamin, Fermentasi, Flavonoid, Flavonol,Iles-iles, Isolasi, Lichen, Malassezia furfur, Metode Brine Shrimp Lethality Test (BSLT), Obat antidiabetes (OAD) Propionibacterium acnes, Obat tradisional, Parkia Speciosa Antibakteri, Pektin, Propionibacterium Acnes, Pseudoefedrin, Saccharomyces Cerevisiae, Spektrofotometri uv sinar tampak, Staphylococcus epidermidis, uji aktivitas antibakteri, Uji sitotoksik, Usnea baileyi. Prosiding ini diterbitkan oleh UPT Publikasi Ilmiah Unisba. Artikel yang dikirimkan ke prosiding ini akan diproses secara online dan menggunakan double blind review minimal oleh dua orang mitra bebestari.
Arjuna Subject : Pharmacology, Toxicology and Pharmaceutics - Ilmu Farmasi
Articles 1 Documents
 1 
Search results for , issue "843 - 852" : 1 Documents clear
Kajian Potensi ROTD Pasien TB-HIV di RS X Periode 2024-2025 Annisa Nur Hasna Fauziyah; Bambang Tri Laksono; Umi Yuniarni
Bandung Conference Series: Pharmacy 843 - 852
Publisher : UNISBA Press

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.29313/bcsp.v6i2.25853

Abstract

Abstract. Tuberculosis (TB) and HIV co-infection increases the complexity of therapy because patients receive antituberculosis drugs (OAT) concurrently with antiretroviral therapy (ART) over a long period, thereby increasing the risk of Adverse Drug Reactions (ADR). This study aimed to determine the types and prevalence of potential ADR during therapy in TB-HIV patients. The study used a descriptive observational design with a cross-sectional approach, with data collected retrospectively from electronic medical records at Hospital X for the period 2024–2025, using a total sampling method based on inclusion and exclusion criteria. A total of 75 patients met the criteria, predominantly male (73.33%) and aged 18–59 years (98.67%), with pulmonary tuberculosis as the most com mon diagnosis (38.67%). All patients received first-line Fixed-Dose Combination (FDC) category-1 OAT, while the most commonly used ART regimen was TDF/3TC/EFV (65.33%). Of the 212 recorded ROTD events, the most frequently occurring were gastrointestinal disorders in the form of nausea and vomiting (20.57%), respiratory disorders in the form of cough (12.44%), and skin disorders in the form of itching (8.61%). These findings indicate that gastrointestinal, respiratory, and skin reactions are the most common adverse effects and require regular monitoring throughout combined TB-HIV therapy. Abstrak. Ko-infeksi tuberkulosis (TB) dan HIV meningkatkan kompleksitas terapi karena pasien mendapatkan obat antituberkulosis (OAT) secara bersamaan dengan terapi antiretroviral (ART) dalam jangka waktu panjang, sehingga meningkatkan risiko terjadinya Reaksi Obat Tidak Diinginkan (ROTD). Penelitian ini bertujuan untuk menentukan jenis dan prevalensi potensi ROTD selama terapi pada pasien TB-HIV. Penelitian menggunakan desain observasional deskriptif dengan pendekatan cross sectional, data diambil secara retrospektif melalui e-rekam medis di RS X periode 2024–2025, dengan metode total sampling berdasarkan kriteria inklusi dan eksklusi. Diperoleh 75 pasien yang memenuhi kriteria, didominasi laki-laki (73,33%) dan berusia 18–59 tahun (98,67%), dengan diagnosis terbanyak tuberkulosis paru (38,67%). Seluruh pasien menggunakan OAT Kombinasi Dosis Tetap (KDT) kategori-1, sedangkan regimen ART yang paling banyak digunakan adalah TDF/3TC/EFV (65,33%). Dari 212 kejadian ROTD yang tercatat, yang paling sering muncul adalah gangguan gastrointestinal berupa mual muntah (20,57%), gangguan pernapasan berupa batuk (12,44%), dan gangguan kulit berupa gatal (8,61%). Hasil penelitian ini menunjukkan bahwa reaksi gastrointestinal, pernapasan, dan kulit merupakan efek samping yang paling sering muncul dan perlu dipantau secara berkala selama terapi kombinasi TB-HIV berlangsung.

Page 1 of 1 | Total Record : 1

 1 

Filter by Year

0000


Reset
Filter By Issues
All Issue Vol. 6 No. 1 (2026): Bandung Conference Series: Pharmacy Vol. 5 No. 2 (2025): Bandung Conference Series: Pharmacy Vol. 4 No. 2 (2024): Bandung Conference Series: Pharmacy Vol. 4 No. 1 (2024): Bandung Conference Series: Pharmacy Vol. 3 No. 2 (2023): Bandung Conference Series: Pharmacy Vol. 3 No. 1 (2023): Bandung Conference Series: Pharmacy Vol. 2 No. 2 (2022): Bandung Conference Series: Pharmacy Vol. 2 No. 1 (2022): Bandung Conference Series: Pharmacy Vol. 1 No. 1 (2021): Bandung Conference Series: Pharmacy 975 - 984 967 - 974 959 - 966 949 - 958 941 - 948 933 - 940 923 - 932 913 - 922 905 - 912 897 - 904 887 - 896 877 - 886 869 - 876 861 - 868 853 - 860 843 - 852 835 - 842 827 - 834 817 - 826 807 - 816 799 - 806 789 - 798 779 - 788 771 - 778 763 - 770 753 - 762 745 - 752 737 - 744 727 - 736 717 - 726 709 - 716 701 - 708 693 - 700 685 - 692 675 - 684 663 - 674 655 - 662 645 - 654 637 - 644 629 - 636 621 - 628 611 - 620 603 - 610 595 - 602 587 - 594 579 - 586 571 - 578 561 - 570 553 - 560 543 - 552 535 - 542 527 - 534 517 - 526 509 - 516 501 - 508 491 - 500 483 - 490 475 - 482 467 - 474 459 - 466 449 - 458 441 - 448 433 - 440 423 - 432 415 - 422 407 - 414 399 - 406 391 - 398 383 - 390 375 - 382 365-374 355 - 364 347 - 354 339 - 346 331 - 338 321-330 311 - 320 303 - 310 295 - 302 285 - 294 275 - 284 265-274 255 - 264 247 - 254 237 - 246 227 - 236 217-226 209 - 216 201 - 208 191 - 200 183 - 190 171 - 182 163 - 170 155 - 162 147 - 154 139 - 146 129 - 138 121 - 128 113 - 120 105 - 112 95 - 104 87 - 94 79 - 86 67 - 78 59 - 66 51 - 58 43 - 50 33 - 42 More Issue